Back to search
FDAFDA · Food and drugs·Recall number F-3526-2017

Major Ferrous Drops, 1 2/3 oz (50 mL)

Published September 20, 2017 · Recall initiated: August 2, 2017

Summary

FDA records food Class II recall F-3526-2017, published September 20, 2017 and initiated August 2, 2017. Recalling firm: The Harvard Drug Group; Status: Terminated; Reported quantity: 63,005 units; Lot: Major Ferrous Drops,1 2/3 oz (50 mL), UPC Number:3 09046 27350 9, All Unexpired Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Harvard Drug Group
Distributor
Domestic: Nationwide to USA Foreign: None VA/DOD: VA CMOP CHARLESTON 3725 RIVERS AVE N. CHARLESTON SC 29405-7038, Ph. 303-339-4305
Lot
Major Ferrous Drops,1 2/3 oz (50 mL), UPC Number:3 09046 27350 9, All Unexpired Lots
Risk classification
Class II
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was Major Ferrous Drops, 1 2/3 oz (50 mL) recalled?

Yes. FDA published recall F-3526-2017 on September 20, 2017. Reported hazard: The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release